Genetics for Healthcare

When doctors speak quickly or use medical terms, patients often leave appointments feeling unsure about what just happened, and that confusion can cost you your life.In this episode Dr. Beatrice Preti explains why it’s crucial to build the confidence to ask questions, to insist on clear explanations, and to push for options that fit your values and lifestyle goals. They discuss real cases where patients who asked for clarity made different choices—choices that preserved quality of life or avoided unwanted side effects, and why chart notes that label someone as “refusing treatment” can misrepresent a patient who simply didn’t understand. She also calls on physicians to take a few minutes to learn who their patients are as people — their goals, work, hobbies, fears — because that context makes it easier to tailor treatments. Listen for these useful ways to communicate with your doctor:Name your goals: tell your clinician what matters most (quality of life, work, hobbies, family)Refuse to accept confusing explanations: confusion is not consent.Take time, if possible, to pause making a decision to think, ask more questions, or get a second opinionBring support: a friend or family member can help ask questions and remember answers.This episode makes a clear case: silence or confusion in the clinic isn’t harmless. Speaking up, asking for time, seeking second opinions, and insisting on explanations aren’t rude — they are essential steps to protecting your health and making care fit your life.META DESCRIPTIONWhat if staying quiet in the doctor’s office cost you the life you want? Dr. Beatrice Preti and host Rome Madison explain why speaking up matters. If medical words make no sense or a treatment plan feels wrong, you must ask questions until you understand. Learn why saying “I don’t get it” is not rude — it protects your health, your goals, and your choices. Hear real stories of patients who changed their care after asking for clarity and learn practical tips for speaking up to make sure you KNOW what’s going on. Doctors also need to listen and spend a few minutes to know who you are beyond the diagnosis. Don’t leave your doctor’s office confused! Your voice shapes your care — use it. Tune in to learn how to build confidence, demand clear answers, and make shared medical decisions with your doctors that fit your life.

In this eye-opening episode, we sit down with Krista Brown, an oncology nurse navigator whose personal journey dramatically exposes the critical knowledge gaps in modern healthcare regarding genetic variants and cancer risk. Despite her professional background, Krista found herself navigating a system where her own ATM variant – a genetic mutation significantly increasing her risk for breast, pancreatic, and ovarian cancers – was largely unknown or misunderstood by her care providers.Krista's family history is poignant: her mother, initially negative for BRCA, later discovered an ATM mutation, which Krista subsequently inherited. This propelled Krista into a proactive health journey, including seeking expanded gene testing and making the courageous decision for a preventative mastectomy. Shockingly, it was during this preventative procedure that early-stage breast cancer was discovered in the pathology, underscoring the life-saving impact of her self-advocacy.Key Takeaways from This Episode:Genetic Literacy is Life-Saving: Learn why understanding your genetic predispositions, even beyond common variants like BRCA, is crucial for early detection and prevention, and how to advocate for comprehensive testing.The Power of Self-Advocacy: Krista's journey highlights the necessity for patients to educate themselves and challenge healthcare providers when their specific genetic risks are overlooked or misunderstood.Nutrition as a Prevention Tool: Discover why integrating proper nutrition is an empowering and actionable step, especially for individuals with genetic predispositions, to actively reduce cancer risk.This episode is a stark reminder that patients can't make informed decisions if doctors aren't educating us on our options. Learn why Krista is now a passionate advocate for genetic literacy in healthcare, emphasizing proactive testing, personalized care, and the often-overlooked role of nutrition in cancer prevention.META DESCRIPTIONDo you know your true cancer risk? Meet Krista Brown, a nurse who had to teach her own doctors about the ATM gene mutation that put her life in danger. This meant she had a much higher chance of getting breast, pancreas, and ovarian cancers. Even though she worked in healthcare, her doctors often didn't know what this specific gene change meant or how to properly help her. Her story exposes a big problem in healthcare: sometimes doctors don't know enough genetics and cancer risks. If they don't have this knowledge, how can they guide you? Learn why it's super important to ask questions, learn about your own genes, and speak up for your health.

Alzheimer’s disease and other neurodegenerative disorders don’t appear overnight—they develop silently in the brain for years. In this episode, we explore how genetics, sleep, and lifestyle combine to shape your brain health, and why precision medicine may be the key to earlier detection and more effective treatment. Dr. Kimberly J Hatchett, The Neuro Doc, breaks down, in plain language, how certain genes increase risk for Alzheimer’s disease, Parkinson’s disease, dementia, and other neurological conditions—and what that means for you and your family. We dive into how cutting‑edge brain imaging, genetic testing, and sleep data are coming together to create truly personalized care plans. Don’t miss these key takeaways:How genetics influence your risk for Alzheimer’s disease and other brain disorders—and why genes are not destiny. Why sleep quality is emerging as a powerful, controllable standard of long‑term brain health. How precision medicine and personalized neurology are changing early detection, diagnosis, and treatment options. Practical steps you can take now to support brain health, even if you have a strong family history of neurological diseases.If you’ve ever wondered whether you should get genetic testing to determine risks for neuro diseases, how to protect your memory, or what sleep for a healthy brain really looks like, this conversation offers an evidence‑based roadmap for proactive brain health. META DESCRIPTIONAre you worried about Alzheimer’s disease or keeping your brain sharp as you age? The Neuro Doc Dr. Kimberly J Hatchett explains brain health in simple, clear language. She talks about how your genes, sleep, and daily habits can raise or lower your risk for Alzheimer’s, dementia, Parkinson’s disease, and other brain problems. You’ll learn what “precision medicine” means and how doctors are starting to use genetics and sleep data to create brain care plans that are personalized for each person. If you want practical ideas to support your brain health today—and better understand your risk for future disease—this episode gives you clear, science-based guidance you can use right away.LINKSDrKimNeuroDoc on TikTokFollow Dr Kim on Instagramdrkimberlyjhatchett.com

In this monumental 50th episode, we celebrate the remarkable journey and courage of Diane Hardesty, a hereditary cancer awareness advocate and cancer previvor. Diane's story is a powerful testament to the life-saving potential of genetic testing. After losing ten family members to cancer, she took the crucial step to undergo hereditary cancer testing, leading to a transformative shift in her family's health trajectory, resulting in zero cancer deaths after testing.We delve into Diane's inspiring path, discussing the importance of awareness, education, and action in the face of hereditary cancer. Diane's powerful message not only emphasizes the significance of genetic testing but also highlights how it can save lives and prevent heartache for generations to come.Key Takeaways:Understanding the impact of hereditary cancer and the importance of genetic testing.Diane's personal experience of losing ten family members to cancer and the turning point she faced.How genetic testing empowered Diane to change her family's future and eliminate cancer risk.Practical advice for those considering genetic testing and navigating their own family histories.Tune in for an episode filled with hope, resilience, and the undeniable message that knowledge truly saves lives!We help you learn the language of precision medicine, and build the confidence to talk to your family and doctors about genetic risks. Become a more effective advocate for your wellbeing and turn sick care into true healthcare! META DESCRIPTION How can you prevent cancer in your family? In this episode, Diane Hardesty shares her powerful story of losing ten family members to cancer before discovering the life-changing benefits of genetic testing. After her testing, she experienced a dramatic shift—there have been no cancer deaths in her family since. This episode emphasizes the critical role of genetic testing in identifying hereditary risks and preventing cancer before it starts. Learn how knowledge of your genetic makeup can inform your choices, leading to early detection, proactive care, and ultimately, saving lives. Diane's journey highlights the importance of awareness and education around genetic testing for families facing cancer risks. Tune in to uncover practical insights on how you can take charge of your health and protect future generations from cancer. Join us for this important discussion on the significant impact of genetic testing in cancer prevention!

In this episode Rome Madison interviews Dr. Marleah Dean Kruzel about her journey as a BRCA2 variant carrier and being a cancer previvor. This has informed her work teaching patient-centered communication to healthcare providers to expand patient access to genetics and genomics. Dr. Kruzel describes how family history led to testing, why she waited to take her test, and how that lived experience shaped her research and teaching. She explains the importance of shared decision-making, and practical skills patients can use to talk to their doctors. The episode also covers the benefits and pitfalls of using social media for genetic information and offers concrete tips to prepare for appointments and limit information overload.Key Takeaways:Before the visit, tell your doctor what you want to talk about most. Try writing out your questions to make sure you get answers.At the end of the appointment, say what you heard in your own words. Let the doctor know how you feel, and ask them to explain if something isn’t clear. Be sure to ask “So what are the next steps?” if you’re not clear. Make sure you and your doctor both agree that you understand.Be careful online—pick a few trusted sites, save what you find, and bring those links or notes to your visit.We help you build confidence and learn the language of precision medicine to become a more effective advocate for your health, wellness and longevity.META DESCRIPTIONEver feel lost when your doctor talks about genes or new treatments? In this episode Dr. Marleah Dean Kruzel — a BRCA2 previvor and expert in health communication — shares how to speak up and get the care you want. You’ll hear her personal story and learn simple, practical steps: tell your doctor what you want to discuss, bring clear questions, repeat back what you heard, and ask “what’s next.” Dr. Kruzel also shows how to use the internet without getting overwhelmed and why small habits — like saying how you feel and asking for plain language — help you make better choices with your care team. This episode gives real tools so you can feel confident at medical visits and stand up for your health. We help you build confidence and learn the language of precision medicine to become a more effective advocate for your health, wellness and longevity.

In this poignant episode, Rome sits down with Mariana Arnaut, the CEO of The After Cancer, to discuss the often-overlooked challenges faced by individuals after cancer treatment. While conquering cancer is a monumental victory, many survivors find themselves grappling with a new set of struggles that can feel isolating and overwhelming. Mariana shares her expertise on navigating the complex landscape of life post-cancer, emphasizing the importance of community support, emotional well-being, and personalized recovery plans.The After Cancer provides a user-friendly app to hospital systems that serves as a vital tool for survivors, offering resources, tools, and peer support all in one place. The app allows users to connect with a supportive community, access educational materials, and track their emotional and physical progress on their healing journey. By fostering connections with others who have lived through similar experiences, users can find strength, encouragement, and practical advice. With personalized features designed to address individual needs, the app empowers cancer survivors to reclaim their lives and navigate the path ahead with confidence. Key Takeaways:Understanding Survivorship: Learn about the unique emotional and physical challenges that cancer survivors face after treatment and why addressing these issues is critical for holistic healing.Building Connections: Discover how fostering a supportive community can empower both survivors and their caregivers, making the journey a shared experience rather than a solitary fight.Practical Resources: Explore the various tools and resources offered by The After Cancer that aid in the transition from patient to survivor, helping individuals reclaim their lives with confidence and purpose.Join us for an enlightening discussion that sheds light on the silent battles fought long after formal treatment ends.META DESCRIPTIONAre you or someone you know navigating life after cancer? Mariana Arnaut, CEO of The After Cancer, shares valuable insights into the unique challenges faced by cancer survivors. Discover how The After Cancer is dedicated to supporting individuals post-treatment through their innovative app, which connects users with resources, a supportive community, and practical tools for emotional and physical healing. Mariana offers tips on coping with the changes that come after cancer and emphasizes the importance of finding strength in community connections. Tune in to learn how to access the support you need and empower your journey toward recovery, making life after cancer easier and more hopeful.

When Stacey Martin received her mother's stage four uterine cancer diagnosis, she never imagined it would lead to discovering her own genetic time bomb. After her mother tested positive for a CDH1 germline mutation during treatment at Mayo Clinic, Stacey faced a 50% chance of carrying the same variant that dramatically increases gastric cancer risk up to 80%. This episode follows Stacey's incredible journey of trusting her instincts at every critical juncture - from advocating for her mother's care, to getting genetic testing herself, and ultimately making the life-saving decision to undergo preventative total gastrectomy. Her brave choice paid off when pathology revealed 17 hidden cancer spots that would have remained undetected through standard surveillance.Stacey shares practical insights about navigating genetic counseling, understanding CDH1-related hereditary diffuse gastric cancer, and building the support systems necessary for major medical decisions. Her story demonstrates how genetic testing and preventative surgery can transform a potential death sentence into empowered survival.Key Takeaways:• CDH1 mutations increase lifetime gastric cancer risk to 70-80% and lobular breast cancer risk to 67%• Preventative total gastrectomy can be life-saving when cancer is undetectable through surveillance• Genetic testing requires careful planning around insurance coverage and support systems• Patient advocacy and seeking centers of excellence are crucial for rare genetic conditionsMETA DESCRIPTIONDo you want to prevent stomach cancer? Meet Stacey Martin — whose mother’s CDH1 test led her to discover she carried the same dangerous gene. This episode follows Stacey’s fight for family, her decision to get genetic testing, and the preventative total gastrectomy that found 17 hidden tumors. A powerful story about the CDH1 gene, gastric cancer risk, cancer prevention, and precision medicine.LINKShttps://hereditarydiffusegastriccancer.org/https://lobularbreastcancer.org/ No Stomach for Cancer

Endeavor Health is proving that precision medicine isn’t just for academic centers or rare-disease clinics. it can be In this episode, Rome talks with Justin Brueck, Vice President of Innovation and Research at Endeavor Health, about how their system has hardwired population genetics into everyday primary care for hundreds of thousands of patients. Justin walks through the evolution of Endeavor’s genomics program from its roots in a 1980s vision for medical genetics to today’s scaled “Genetic and Wellness Assessment” embedded in Epic. He explains how they designed guideline-based workflows that allow primary care clinicians—not geneticists—to safely order testing, and how new roles like Genetic Counseling Assistants and dedicated consult clinics keep the system from getting clogged while ensuring patients get appropriate follow-up.The conversation also dives into what the data show: high patient acceptance, manageable anxiety, meaningful detection rates, and strong health-economic signals that routine genetic testing can reduce the costs of late-stage cancer and other chronic diseases. Justin ends with practical advice for health systems that want to build similar programs, and guidance for patients who want genetic screening but haven’t been offered it by their current providers.Key Takeaways for Health System LeadersGuideline-based survey questions and decision support in Epic automatically surface who should be offered genetic testing.The program is designed to be equitable, with targeted outreach to communities (e.g., safety net hospital and the Vietnamese patient population) using trusted local messengers.Routine genetic testing supports earlier detection, guideline-based prevention, and reduced downstream costs, especially as systems move toward value-based care.META DESCRIPTIONDiscover how precision medicine is changing cancer prevention and everyday healthcare. Justing Bruek, VP of Innovation and Research at Endeavor Health explains how they were able to move from “wait until you’re sick” care to proactive disease prevention by adding a short genetic and wellness survey to annual checkups can flag patients who may need advanced screening for cancer and other rare conditions. Their publications support how this approach supports early detection, reduces late-stage cancer, improve outcomes, and lower the long-term cost of care—all while giving patients more power over their health.

JJ Singleton was a 27-year-old athlete from the small Appalachian town in North Carolina, when he was diagnosed with aggressive colorectal cancer. His story highlights the alarming rise of early-onset colorectal cancer, a disease now the leading cause of cancer death for men under 50. Growing up in a rural community where going to the doctor was often avoided and early death was dismissed as "God's will," JJ wasn’t diagnosed with colon cancer until a visible tumor throbbed in his abdomen. His journey from brutal chemotherapy failures to a life-stabilizing immunotherapy clinical trial at Duke is a powerful testament to the promise of precision medicine—turning terminal cancer into a manageable chronic condition.Yet, his story also exposes a critical cancer care disparity: the immense difficulty rural patients face in accessing the very trials that could save them. This episode explores how geography, limited resources, and a lack of knowledge about accessing healthcare as a preventative strategy creates an intimidating barrier between rural Americans and cutting-edge care. Key Takeaways:Early-Onset Crisis: Colorectal cancer is rising dramatically in adults under 50 and is now a leading cause of cancer death in this age group.Rural Disparity: Where you live is a major social determinant of health, creating significant barriers to screening, specialist care, and life-saving clinical trials.Chronic Disease Potential: Immunotherapy and precision medicine trials are beginning to successfully turn some advanced, active cancers into controllable chronic conditions.We amplify Colorectal Cancer Awareness Month with JJ's personal advocacy to a national conversation on prevention, breaking stigma, and the systemic changes needed to bridge the gap to precision medicine for every patient, regardless of their zip code.Follow JJ Singleton X Facebook Instagram META DESCRIPTIONThis podcast episode shares the incredible journey of JJ Singleton from rural Appalachia diagnosed with aggressive colon cancer at age 27. After struggling through harsh chemotherapy, he found new hope through an immunotherapy clinical trial using Keytruda (pembrolizumab), which has successfully stabilized his cancer and allowed him to live a full, active life for years—showing how modern treatments can turn cancer into a manageable chronic condition. We also tackle the alarming rise of early-onset colorectal cancer in younger adults, and the vital importance of cancer screening and breaking stigma around symptoms. Learn the language of precision medicine and build the confidence to talk to your doctor and family, and become an effective self-advocate for a precision medicine approach to your healthcare.

Marianne Pearson, VP of Patient Care and Lindsey Glaspell, Clinal Nurse Navigator at the Colorectal Cancer Alliance, join Rome for a blunt, funny — but deadly serious — briefing on colorectal cancer prevention. Marianne breaks down how knowing your family history and normalizing talking about your poop habits are just as important as timely screening with colonoscopy and stool tests to prevent colon and rectal cancer. She also shares how her dedicated advocacy for others, helped detect her own cancer at an early stage that likely saved her life. Lindsey adds a sharp, practical perspective on everyday prevention: how to prepare for a colonoscopy, when to start screening, and which biomarkers matter for treatment planning and prevention strategies. Tumor biomarker analysis, and genetic screening for hereditary syndromes like Lynch Syndrome that drive earlier detection and better outcomes. Key Takeaways: Colonoscopy saves lives: starting at age 45 guideline-based colon and rectal cancer screening remains the top prevention tool. Biomarkers can change care: tumor and germline biomarkers guide treatment and identify at-risk relatives for targeted surveillance. Genetic testing for Lynch and other hereditary CRC syndromes enables testing of relatives that can prevent cancer in the family tree. Subscribe to Genetics for Healthcare and get our newsletter —bite-sized updates on past episodes delivered monthly. Click Subscribe now and never miss life-saving practical tips to prevent cancer. META DESCRPTION Did you know talking about your poop habits can save your life? This podcast talks about colon and rectal cancer screening, what you don’t wanna do ….. and what you do wanna do. Learn why biomarkers are so important in colorectal cancer, how knowing your family history and genetic testing can prevent colon cancer for your future generations. Don’t ignore your poop! Learn what to ask your doctor, how to get tested, and where to find help. Don’t wait: screening saves lives! We help you learn the language and build the confidence to talk about precision medicine with your doctors and family. This is GENETICS FOR HEALTHCARE—a podcast helping turn sick care into true healthcare! We are dedicated to helping patients and caregivers learn the language and build the confidence to advocate for precision medicine in treatment, survivorship, disease screening, and prevention. 2025 State of Screening Study Why are Biomarkers Important for Colorectal Cancer? Types of Biomarkers for Colorectal Cancer How to talk to your doctor about colorectal cancer screening? Genetics For Healthcare: Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0 Facebook: https://www.facebook.com/GeneticsForHealthcare Instagram: https://www.instagram.com/geneticsforhealthcare/ TikTok: https://www.tiktok.com/@genetics.for.healthcare LinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

She thought she was just another woman with lumps and dismissive doctors until a simple saliva test rewrote her future. Veronica Tucker’s story rips through complacency: from being told “(the cancer) is on your father’s side, don’t worry”; the gut-punch of a BRCA2 positive result, to the wrenching choices of double mastectomy and hysterectomy before cancer could take hold. This episode traces the raw, unfiltered emotional moments of fear and hurt when care failed her, and the courageous clarity that followed when she chose prevention over waiting for diagnosis.Hear how one sorority conversation unlocked access to a compassionate genetic counselor who transformed Veronica trauma into options and action. She exposes how defensive doctors and ignorance about hereditary cancer still cost lives, and why refusing to be passive about risk is the bravest kind of self-advocacy.Key takeaways:Ask for genetic testing: one saliva sample can shift your life from reaction to prevention.Build your Spark team: community, counselors, and advocates are essential for making and surviving preventive choices.Don’t accept dismissal: push for answers, document interactions, and demand care that treats prevention as urgent.This is not a gentle patient story. It’s a provocation: know your genes, organize your family, and insist on prevention. Veronica’s journey proves cancer prevention is not theoretical, it’s a series of tough, courageous choices that can save generations. Meta DESCRIPTIONListen to this powerful story about how a simple saliva genetic test prevented a cancer diagnosis in a family with a long history of cancer. Veronica Tucker discovered she carried a BRCA2 variant that increased her chances of breast and ovarian cancer. She shares the problems she faced when doctors dismissed her concerns, and why she now speaks up for patients who are afraid to ask questions. Listen to learn why knowing your genetic risks can change everything, how to start family conversations about testing, and how to find people who will support you through prevention choices.

We are honored to speak with Amy Cohen, who made history as the first person with sickle cell disease to run and finish the New York City Marathon. She opens up about her diagnosis, and the pivotal moment in high school when the reality of the disease set in, emphasizing the necessity of pushing through fear and living boldly against external limitations.Amy frames her marathon finish not as a solitary victory, but as a win for the entire sickle cell community, offering a new narrative of possibility. It also connects to her professional mission as a patient advocate and founder of The Patient Room consultancy, which focuses on bridging the critical trust and information gap between pharmaceutical developers and the patients they serve.Key Takeaways:Learn the three mindset shifts essential for thriving with a chronic illness, moving from limitation to possibility.Understand the critical importance of a supportive care team and community in achieving ambitious health goals.Discover why policy changes, like cuts to ACA subsidies, directly threaten care access and worsen outcomes for patients even as new therapies emerge.This is a compelling call to action for protecting the systems that enable precision medicine, and allow all patients to pursue their own finish lines.META DESCRIPTIONHear how Amy Cohen, a woman with sickle cell disease, made history by running the New York City Marathon. She shares her story of using a strong mindset and a great doctor's plan to break her own limits. Amy talks about how she trained for years and why her win is a win for all sickle cell warriors. Amy passionately explains why losing ACA health insurance help would hurt people with sickle cell in ways most cannot imagine.

In this episode research geneticist and author Susan Liebman joins us to tell the personal and scientific story behind her memoir The Dressmaker’s Mirror: Sudden Death, Genetics, and a Jewish Family’s Secret.Susan unpacks generations of silence around heart disease and how sudden deaths and a decades-long family history of dilated cardiomyopathy led her to the discovery of an FLNC gene mutation (a "founder variant" most prevalent in Ashkenazi Jewish families) which revealed both risk and opportunity for preventing sudden cardiac death.Top 3 takeaways listeners will learn:Why dilated cardiomyopathy can be hereditary and how to get free genetic testing to find a treatable genetic variant.How precision medicine (including targeted screening, medications, implantable defibrillators, and soon gene editing) can change outcomes in cardiomyopathy — yet fewer than 1% of people with this condition currently receive germline genetic testing.Practical advice for starting conversations with family and clinicians, and how applying genetic knowledge can turn family grief into prevention for future generations.If you or a loved one has been diagnosed with heart failure or idiopathic dilated cardiomyopathy, this episode is a must-listen! It blends gripping storytelling with clear, actionable information about genetic testing, genes associated with heart failure and how knowing can help you gain access to precision medicine that could save lives for generations to come.META DESCRIPTIONSusan Liebman talks about cardiomyopathy, sudden death and family secrets. Her book is a love letter to family and shows how precision medicine found an FLNC gene mutation that can cause sudden death. Genetic testing can lead to treatments, preventative screenings, and lifesaving choices—yet fewer than 1% of cardiomyopathy patients get tested. We help you build the language and confidence to advocate for a precision medicine approach to your healthcare.

In this powerful episode of Through The Pain, we dive deep into the lived realities behind diagnosis, treatment, and the emotional weight patients often carry in silence.Too often, patients receive life-altering information without the context, clarity, or support needed to truly understand what’s happening to their bodies. In this conversation, Christelle Salomon and Wunmi Bakare unpack what that gap feels like—from confusion and isolation to the struggle of navigating complex medical systems that weren’t built with patient understanding at the center.This episode goes beyond science and clinical terminology. It highlights the human experience behind the data: the loneliness of feeling unseen, the frustration of unanswered questions, and the importance of community, communication, and trust between patients and healthcare providers.We explore why translating complex medical information matters, how advocacy changes outcomes, and what it means to truly listen to patients—not just treat them. This conversation is for patients, caregivers, advocates, clinicians, and anyone who believes healthcare should be rooted in empathy as much as expertise.If you’ve ever felt overwhelmed after a diagnosis, unsure of what questions to ask, or disconnected from the care process, this episode will resonate deeply. And if you work in healthcare, this is an essential reminder of why understanding lived experience is just as critical as understanding disease. Watch, listen, and reflect—because real progress begins when patients are heard.

Hot off the stage speaking at the World Economic Forum in Davos, Switzerland, I spoke with Mark Amouzgar, founder of March Health about:how AI-powered “digital twins” can accelerate precision medicinethe hard truth about protecting patient privacy as this tech scalesWorld Economic Forum is about fostering global cooperation on complex issues that drive economic growth and resilience.If you follow AI, genomics, or the future of healthcare, this episode gives clear, timely insights from a leader working at the intersection of genetics and machine intelligence.The Genetics for Healthcare Podcast bringing the World Economic Forum to Your Ears!

Rome sits down with Stephane Budel, Founding Partner at Decibio, a premier strategy consulting firm dedicated to advancing precision medicine. This conversation aims to demystify the complex world of NGS testing, providing patients, caregivers, and healthcare professionals with a clearer understanding of how these powerful tools are revolutionizing cancer prevention, treatment, and long-term management.Stephane offers a comprehensive overview of the NGS testing landscape, detailing its various applications from identifying hereditary cancer risks and early detection, to guiding personalized treatment with comprehensive genomic profiling (CGP) and monitoring disease recurrence (MRD testing). They candidly discuss the persistent challenges in NGS adoption, which include lack of insurance coverage, and integrating these technologies into routine clinical workflows, particularly in community settings.Key Takeaways:NGS Transforms Cancer Care: Next-Generation Sequencing is crucial for shifting from a reactive "sick care" model to proactive, precision medicine to prevent cancer. By enabling earlier detection and highly personalized treatments, NGS significantly improves patient outcomes, particularly when cancer is caught in its earliest stages.A Spectrum of NGS Tests: Patients have access to various NGS applications throughout their cancer journey, including germline testing for hereditary risk, early detection tests (e.g., multi-cancer early detection blood tests), comprehensive genomic profiling (CGP) for treatment selection, and monitoring (MRD) tests for tracking disease and recurrence.The Future of Cancer Care: The integration of AI and multiomics (analyzing DNA, RNA, and proteins) will enhance diagnostic accuracy, personalize therapeutic strategies, streamline clinical workflows, and unlock deeper biological insights, further optimizing patient care in the coming years.META DESCRIPTION Discover how NGS testing is changing cancer care! DeciBio co-founder Stephane Budel explains precision medicine and how genetic tests help treat and prevent cancer. Learn about different types of NGS tests, like liquid biopsies, and what they mean for you. This episode makes complex topics simple, giving patients and caregivers clear information on how to advocate for your health and understand the future of cancer care with precision medicine. Tune in to empower yourself with knowledge about NGS testing and personalized treatment options. We help you learn the language and build confidence to be a more effective advocate for a precision medicine approach to your healthcare.

This week we sit down with Sara Kavanaugh, the voice behind The Positive Gene Podcast, who shares her deeply personal story as a cancer pre-vivor. Discovering not one, but two gene variants that significantly increased her cancer risk, Sara transformed her fear and anxiety into powerful action. This conversation about genetics redefines what it means to face cancer risks empowered and illuminates how initial anxiety can evolve into profound personal power and a confident approach to healthcare.Sara details the proactive and life-changing decisions she made using precision medicine. From preventative surgery to tailored screening protocols, all guided by her genetic testing results. We explore why she started her podcast and her dedicated advocacy work, emphasizing the critical role of genetic counselors and supportive communities like FORCE in navigating complex health information and fostering true healthcare ownership. This isn't just about her story; it's a blueprint for others to activate their personal power and confidence with precision medicine.LINKS⁠Her website⁠⁠podcast links⁠⁠NSGC.ORG find a GC⁠⁠FORCE⁠Guidelines for screening for variant? ⁠CDC Managing Risk for Cancers Related to Lynch Syndrome⁠⁠FORCE Gens by Syndrome⁠⁠FORCE CHK2 screening recommendations⁠

In this special New Year's episode, host Rome Madison steps into the interviewee chair, sharing the driving force behid his two-decade career in precision medicine with DNA Today Podcast host Kira Deneen. Rome recounts his unexpected entry into the field, and a self-taught pursuit of molecular science that led him to market groundbreaking cancer diagnostics. Rome's reveals that his passionate mission to expand patient access was birthed when his own father was diagnosed with colorectal cancer. This coupled with the serendipitous fact that his father's surgeon and the hospital where he received care were also his clients, which ensured his father received the genomic insights few patients got access to at the time. Rome’s father today is a 20-year colorectal cancer survivor, which fuels his relentless fight to eliminate obstacles for people to acces genetic and genomic testing today.Kira Dineen is a certified genetic counselor the host and executive producer of DNA Today, a weekly podcast that educates and engages listeners about genetics. Kira has produced over 300 episodes of DNA Today, interviewing experts in the field of clinical genetics and has won the Best 2020, 2021, and 2022 Science and Medicine Podcast Awards.Listen for these powerful takeaways:The Power of Personal Experience: Rome's direct involvement in his father's colorectal cancer surgery and genomic testing profoundly solidified his lifelong mission to expand patient access to genetic and genomic testing.Persistent Access Barriers: Despite two decades of scientific advancement in precision medicine, significant hurdles such as outdated reimbursement policies, lack of provider awareness, and inherent biases continue to prevent equitable access.The Imperative of Self-Advocacy: Rome emphasizes that accessible information and patient empowerment are crucial for navigating the complex healthcare system, enabling individuals to advocate for and ultimately receive personalized, genome informed care.

We’re taking a look back at the podcast's remarkable growth and engagement throughout 2025. Nearly 5000 podcast downloads, listeners in 59 countries and counting, and the expanding reach across platforms like YouTube and LinkedIn is helping us to reach more people who need to learn the language of precision medicine and build confidence to be more effective advocates for their healthcare. Rome also unveils exciting new website features designed to make this information more accessible, including a glossary of terms, a list of patient advocacy groups, and an advanced search function to find topics most important to you.Adding a personal touch, Rome introduces his daughters and podcast contributors, Marloh and Zoi, offering listeners a chance to get to know the family behind the mission, and even includes a brief cameo from their beloved dog, Cyrus. The episode culminates with an inspiring interview featuring former NFL defensive lineman Tony Savage, a male breast cancer survivor and BRCA2 variant carrier, whose powerful story underscores the importance of proactive genetic testing to understand cancer risks. Before the interview, Rome outlines ambitious goals for the podcast's future, aiming to further expand its impact and advocate for greater integration of genetic insights in healthcare:Syndicate Genetics for Healthcare Podcast episodes into Cancer Center Waiting Rooms/Hospital Wards – we want to repurpose our video content, particularly the patient testimonies, to be featured in cancer center waiting rooms and hospital cancer wards. These real-life stories and educational segments can engage, inform, and inspire patients during their healthcare journeys, turning solemn waiting times into opportunities for learning and connection.Advocate for NFL's Crucial Catch Campaign to Include Genetic & Genomic Testing - This initiative would emphasize the importance of hereditary cancer testing, whole genome sequencing, and identifying high-risk variants early to inform proactive screening, prevention strategies, and ultimately, save lives by catching diseases when they are most treatable.If you have connections within healthcare systems or ideas on how to license or syndicate our episodes AND/OR contacts within the NFL, or experience in large-scale health advocacy campaigns, we'd love to hear from you! Send us an email at [email protected] or DM us on any of our social medial platforms.

Rome reconnects with Dr Tabari Baker, medical affairs executive and pioneer in the Medical Science Liaison (MSL) role. We learn how MSL have become critical connectors to revolutionize patient access to precision medicine. As genetic and genomic testing, particularly NGS, becomes increasingly central to healthcare, MSLs serve as the vital resource to clinicians, translating complex clinical science into practical applications that directly benefit patients.Discover how Dr. Baker's work and the broader MSL community empower clinicians to interpret and apply the fast-growing title wave of genomic insights, especially as precision medicine expands beyond oncology into areas like cardiology, neurology, and rare diseases.Dr. Baker also shares invaluable insights and three essential tips for aspiring MSLs, drawing from his dynamic leadership style and passion for medical innovation and health equity. If you're curious about the unsung heroes who fast-track cutting-edge science to the patient's bedside, this episode offers a profound look into their critical role.META DESCRIPTIONWant to know how patients get the newest gene treatments faster? Dr. Tabari M. Baker explains how Medical Science Liaisons help doctors understand the latest gene science. This includes new tests like NGS testing and precision medicine. MSLs make sure these new precision medicine treatments reach patients more quickly. They work in areas like cancer, heart, and rare diseases. Learn the language and build confidence to advocate for a precision medicine approach to your healthcare! #geneticsforhealthcare

In this powerful conversation Rome talks with breast cancer conqueror Mary Royal, who shares her deeply personal experience with the fear and anxiety of cancer recurrence. Mary’s story takes a pivotal turn when she’s introduced to MRD (Molecular Residual Disease) testing, a groundbreaking technology also known as circulating tumor DNA (ctDNA) or form of liquid biopsy testing.This innovative test detects minute fragments of cancer DNA shed by tumor cells into the bloodstream, often long before any symptoms appear or before traditional imaging scans can identify a relapse. MRD testing has potential to revolutionize the detection of cancer’s return after curative treatment by providing doctors 15-month (or more) lead time to catch a returning cancer at its earliest, most treatable stage, transforming what might have otherwise become an incurable situation into longer healthier life.Mary's narrative is not just about her fight against cancer; it's a testament to overcoming fear, advocating for cutting-edge care, and championing a technology that promises to empower patients and redefine the future of cancer surveillance and treatment.META DESCRIPTION:Stop worrying if cancer will come back! Learn how MRD testing molecular residual disease (ctDNA/liquid biopsy) helps. Hear from Mary Royal, who beat breast cancer, about this special test. It finds tiny bits of cancer before a scan can. Learn how MRD testing can ease fear and anxiety and help avoid incurable cancer. We help you build the language and confidence to advocate for a precision medicine approach to your healthcare.

In this groundbreaking discussion, Rome talks with Dr. Ronan Kelly, Director of Scientific Discovery and Precision Medicine at Baylor University Medical Center, and Chief of Oncology for the Baylor Scott & White Healthcare System, the largest non-profit health system in Texas, spanning vast rural and urban landscapes. Dr Kelly unveils how the visionary Texas Cancer Interception Institute is breaking down traditional barriers to empower patients with precision medicine insights, ensuring early intervention, improved cancer outcomes, and a future where proactive health management is the norm.The institute is leveraging emerging diagnostics and cutting-edge technologies, including multi-cancer early detection blood tests (MCDs), at-home cancer screenings, and advanced AI analytics. By making these powerful tools accessible through patient-centric digital platforms and smartphone integration, BSW is not just performing tests but transforming the entire cancer diagnostic journey. Key Takeaways:Proactive Interception: Discover how early detection through advanced diagnostics like MCD blood tests and at-home genetic screenings is the cornerstone of the national strategy to drastically reduce cancer mortality.Accessible Precision Medicine: Learn about the innovative use of smartphones, AI, and patient navigators to simplify access to cutting-edge tests, and guide patients through their diagnostic journey, even from home.Beyond Traditional Screening: Understand the shift from relying solely on imaging to integrating circulating biomarkers (blood, urine, cheek swab tests) for detecting a wider range of cancers earlier.LINKS: Texas Cancer Institute

Rome talks with Dr. Osagie Ebekozien, Chief Quality Officer of the American Diabetes Association (ADA), for a powerful conversation around the staggering $413 billion annual cost of diabetes in the U.S. Dr. Ebekozien illuminates 85 years of the ADA’s work and how precision medicine offers a vital path to preventing diabetes and mitigating its profound impact on health and healthcare budgets. He also shares his personal inspiration for fighting diabetes and explains the crucial link between diabetes and obesity, highlighting how conditions like prediabetes affect millions and escalate costs.Discover the transformative role of modern treatments like GLP-1s, a true success story of precision medicine, and programs like the National Diabetes Prevention Program in delaying or preventing the disease. Dr. Ebekozien emphasizes that by taking an active role in understanding your health, engaging with care providers, and advocating for widespread solutions, we can collectively reduce this epidemic and ultimately cure diabetes. Key Takeaways:The Alarming Cost: Diabetes drains $413 billion annually from the U.S. economy, often impacting family budgets through complications.Precision Prevention: Genetic testing helps identify diabetes subtypes (e.g., monogenic, T1D stages) for earlier, more effective interventions.GLP-1's Impact: Medications like GLP-1s showcase the power of precision medicine in managing diabetes and obesity, improving outcomes significantly.Empowering Action: Learn practical steps for understanding personal risk, preventing prediabetes from progressing, and advocating for better care.

this powerful episode, former Kansas City Chiefs great Art Still shares his personal journey with hereditary ATTR amyloidosis (hATTR), a genetic mutation affecting 1 in 25 African Americans. Art discusses how years of playing in the NFL masked the symptoms of this underdiagnosed condition, which can lead to heart failure and other serious health issues. He emphasizes the importance of genetic testing and early detection to manage the disease and extend your shelf life.Art's commitment extends through his foundation, STILL4LIFE.org, where he shares his story and provides resources for others affected by hATTR. The foundation aims to bridge the gap between the medical community and the public, using accessible language to explain complex genetic concepts. Discover how STILL4LIFE.org is empowering individuals and families to navigate the challenges of hATTR and advocate for their health.Key Takeaways:hATTR is an inherited genetic condition that often results in heart failure early in lifeSymptoms like numbness in feet and hands, unexplained lower leg swelling and carpal tunnel may be signs of hATTRGermline genetic testing can help with timely diagnosis and managementBlack Americans are disproportionately affected by hATTRRaising awareness and improving trust in healthcare are crucial for early detectionFor more information about hereditary amyloidosis visit https://www.attrrevealed.com/META DESCRIPTIONEver heard of a tricky heart problem called hATTR? Kansas City Chiefs great Art Still did! He shares his story about playing NFL football, finding out he had this genetic variant, and how it affects his family. It's more common in some groups, especially African Americans. Learn the signs like trigger finger, leg swelling and rotator cuff injuries and others doctors do not recognize as hATTR. Art's here to help us understand our bodies and families better! He talks about his group, STILL4LIFE.org, that helps people learn about hATTR. We help you learn the language and build confidence to be an effective advocate for a precision medicine approach to your healthcare.LINKSATTRreveal.comstill4life.org

We delve into the world of pancreatic cancer with Pamela Acosta Marquardt, founder of the Pancreatic Cancer Action Network (PanCAN), and Julie Fleshman, its president and CEO, to discover the inspiring story behind PanCAN's creation and the remarkable progress made in the fight against this challenging disease.PanCan’s patient advocacy has revolutionized pancreatic cancer research funding, treatment options, and survival rates, transforming a landscape once marked by despair into one filled with hope. We discuss PanCAN's ambitious five-year plan to further improve outcomes, the importance of precision medicine - genetic and genomic testing, and emerging research on the link between new-onset diabetes and pancreatic cancer. This episode provides crucial insights and practical tips for patients, families, and healthcare professionals seeking to navigate the complexities of pancreatic cancer care.Key Takeaways:Precision Medicine: genetic and genomic biomarker testing are essential for personalized treatment approaches, and all pancreatic cancer patients should ask for these tests.PanCAN's Patient Services Program offers free case management to help patients and families navigate diagnosis, treatment, and support resources.PanCAN's efforts have contributed to increasing the five-year survival rate from 4% to 13%, with a goal to reach 20% in the next five years.

In this episode filmed on location in Las Vegas, Rome and his guests dive deep into the groundbreaking advancements in AI-driven precision medicine showcased at the HLTH USA Innovation conference. This is not just another conference – it's the epicenter of healthcare innovation! This episode serves as your insider's guide to HLTH, the largest healthcare technology show on the planet, attracting over 12,000 attendees from across all facets of the health care industry. We break down what makes HLTH so important and explore why it's the place to be for anyone shaping the future of healthcare. Hannah Mamauszka and Lena Chaihorsky, co-founders of Alva10 join Rome as co-hosts to explore how AI is addressing the rising consumer demand for personalized healthcare solutions. The episode features insights from: Ivory Bennett BRCA2 variant carrier and Type 1 Diabetes Patient Advocate: expressing the importance of awareness and educating yourself for the benefit of your future generations Jim Foote, CEO First Ascent BioMedical: Discusses "functional precision medicine" and how AI enables real-time adjustments based on an individual's environment. Lorna Bornstein CEO - Grokker: Explores AI's role in maximizing health benefits utilization and driving down costs for both members and plans. Lior Rauchberger CEO - Gene By Gene: Highlights AI's potential in genomics to "hyper-personalize" healthcare. Key takeaways include: the convergence of healthcare and technology, AI's impact on making precision medicine more accessible and affordable, and the importance of connecting diagnostics, data, and personalized care delivery in a meaningful way. Whether you're a healthcare professional, an investor, or simply curious about the future of health, this episode will give you a comprehensive understanding of what HLTH is and why it's essential to the conversation. This is GENETICS FOR HEALTHCARE—a podcast helping turn sick care into true healthcare! We are dedicated to helping patients and caregivers learn the language and build the confidence to advocate for precision medicine in treatment, survivorship, disease screening, and prevention. Genetics For Healthcare: Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0 Facebook: https://www.facebook.com/GeneticsForHealthcare Instagram: https://www.instagram.com/geneticsforhealthcare/ TikTok: https://www.tiktok.com/@genetics.for.healthcare LinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

WARNING: may cause extreme disdain to health insurance companies and PBMsIn this raw and revealing episode, Rome sits down with Matthew Zachary, cancer survivor, advocate, and host of the Out of Patients podcast. Matthew's journey is one of resilience and righteous rage. He dissects the broken healthcare system with strait talk, revealing how it's "working exactly as designed"……. to put profits over patients.Key Takeaways:How to advocate for yourself or someone you love in a complex healthcare systemHow genetics + genomics + AI gives power to the people to be the CEO of your healthcareFinding you voice! Turn your personal struggles into a force for change! They discuss how precision medicine + AI are sparking a Cancer Rights Revolution," arming patients with the knowledge to challenge the status quo. Matthew shares how sometimes "the best treatment is saying 'No Thanks' to the status quo," empowering listeners to become their own best advocates. Prepare for uncomfortable truths, actionable insights, and a healthy dose of snark as Matthew Zachary ignites a firestorm of change.

In this episode filmed on location in Las Vegas, Rome and his guests dive deep into the groundbreaking advancements in AI-driven precision medicine showcased at the HLTH USA Innovation conference. This is not just another conference – it's the epicenter of healthcare innovation! This episode serves as your insider's guide to HLTH, the largest healthcare technology show on the planet, attracting over 12,000 attendees from across all facets of the health care industry. We break down what makes HLTH so important and explore why it's the place to be for anyone shaping the future of healthcare.Hannah Mamauszka and Lena Chaihorsky, co-founders of Alva10 join Rome as co-hosts to explore how AI is addressing the rising consumer demand for personalized healthcare solutions.The episode features insights from:Ivory Bennett BRCA2 variant carrier and Type 1 Diabetes Patient Advocate: expressing the importance of awareness and educating yourself for the benefit of your future generationsJim Foote, CEO First Ascent BioMedical: Discusses "functional precision medicine" and how AI enables real-time adjustments based on an individual's environment.Lorna Bornstein CEO - Grokker: Explores AI's role in maximizing health benefits utilization and driving down costs for both members and plans.Lior Rauchberger CEO - Gene By Gene: Highlights AI's potential in genomics to "hyper-personalize" healthcare.Key takeaways include: the convergence of healthcare and technology, AI's impact on making precision medicine more accessible and affordable, and the importance of connecting diagnostics, data, and personalized care delivery in a meaningful way.Whether you're a healthcare professional, an investor, or simply curious about the future of health, this episode will give you a comprehensive understanding of what HLTH is and why it's essential to the conversation.

This episode dives into how innovative technologies are enabling point-of-care clinical decision support, ensuring patients gain seamless access to potentially life-saving genetic information throughout their healthcare journey.Rome and ⁠Feyi Ayodele, CEO of Cancer IQ ⁠and one of Modern Healthcare's 2024 Innovator's List, explore strategies to break down traditional barriers to patient access that empower primary care physicians (PCPs) and specialists to integrate genetic and genomic insights directly into routine appointments. Discover how digital solutions are transforming patient selection for hereditary cancer testing – including crucial breast cancer risk assessments – and streamlining access to precision medicine. We'll also uncover how these advancements are fostering a more proactive and equitable healthcare landscape. Key Takeaways:Point-of-Care Clinical Decision Support: Understand how digital tools are empowering healthcare providers with real-time access to guidelines to identify patients who would benefit most from genetic testing.Democratizing Access: Explore strategies for overcoming geographic and socioeconomic barriers, ensuring equitable access to hereditary cancer testing and precision medicine for all.Informed Decision-Making: Discover how digital platforms are facilitating informed conversations between patients and providers about risk assessment, personalized prevention, and genetic testing options.Empowering Self-Advocacy: Gain insights into how patients can leverage these technological advancements to become more effective self-advocates for their genetic health.We help you build the language and confidence to become a more effective self-advocate for precision medicine.

Genetic counselors are essential healthcare professionals, expertly decoding complex genetic information and guiding patients through life-altering medical decisions. They translate the language of our genomes into understandable insights, helping families navigate hereditary risks and personalize treatment plans.But the role extends far beyond the science. GCs are trained to deliver difficult news with empathy, providing psychosocial support during traumatic healthcare discoveries.In this episode, Rome speaks with Kate Wilson, licensed genetic counselor, host of the All Access DNA podcast, and genetics professor at Emory University. She illuminates the demanding dual role of genetic counselors – interpreting genetic variations while navigating the emotional fallout for patients and families. We discuss the challenges GCs face due to a lack of Medicare recognition and fair reimbursement.Key Takeaways:Understand the unique skillset of genetic counselors (GCs): expertise in genetics and psychosocial support.Learn how GCs guide patients through complex genetic test results and potential health implications.Explore the challenges GCs face due to lack of Medicare recognition and fair reimbursement.Discover how this lack of recognition impacts patient access to crucial genetic services and disease prevention.

In this eye-opening episode, we delve into the often-overlooked crisis of financial toxicity in the world of breast cancer. Molly MacDonald, the inspiring founder and CEO of The Pink Fund, an organization providing critical cancer financial support for non-medical expenses to breast cancer patients in active treatment. Molly paints a vivid picture of how financial toxicity creates a ripple effect, impacting not only a patient's ability to afford treatment, but also their mental health, family stability, and overall quality of life.Learn more about The Pink Fund and help them build a financial bridge for families in need.This episode is a must-listen for anyone affected by breast cancer, healthcare professionals, and those seeking to understand the systemic challenges faced by cancer patients. We explore the innovative partnerships The Pink Fund has forged with major corporations like Ford and CVS, and discuss how these collaborations amplify their reach and impact.Key Takeaways:Financial toxicity is a significant and often overlooked side effect of cancer, impacting a patient's ability to afford treatment and maintain their quality of life.The Pink Fund provides crucial cancer financial support by covering non-medical expenses for breast cancer patients, helping them avoid financial ruin and focus on healing.Early screening for financial concerns and access to financial navigators are essential for identifying and addressing the financial challenges faced by cancer patients.Corporate partnerships play a vital role in expanding the reach and impact of organizations like The Pink Fund, enabling them to provide broader cancer financial support.Individuals can make a difference by supporting organizations like The Pink Fund, advocating for policy changes, and raising awareness about the impact of financial toxicity on cancer patients and their families.

Thank you for tuning into GENETICS FOR HEALTH CARE . . . A podcast dedicated to helping patients and their caregivers advocate for a precision medicine approach to treatment, disease screening and prevention. You can find us on Spotify, Apple Podcast, YouTube LinkedIn Facebook and Instagram….soon on TikTok! Please hit that SUBCRIBE button on YouTube to get alerts and updates on new episodes like this one! Jemma Sutton, 2x breast cancer survivor and patient advocate Emersed herself in the world of genetics & genomics Share her story and Some people have to fight for access to biomarker testing or genetic & genomic testing….…………..some have to fight for access to certain therapies. You had to fight to be diagnosed with breast cancer [young age, not in screening guidelines] Told to come back in 6mo Self funded 🡺 4 MRI, bloodwork, 4 ultrasounds, xray, mammo Cat led to diagnosis Tell us about your experience and how you eventually were diagnosed with breast cancer. BC subtype? 🡪 luminal A Stage / Grade Treatment recommendations? Were you offered hereditary cancer testing? In the UK, routine screening recommendations start at age 50. In the US, the U.S. Preventive Services Task Force (USPSTF) recommends that women at average risk for breast cancer begin screening with mammograms every two years at age 40 and continue until age 74. You’ve been vocal about changing those screening guidelines. Why start screenings at age 40? 21% of new breast cancers diagnosed before age 50 Globally, cases of women diagnosed with BC befor age 50 has increased by 80% over last 30yrs Sign the petition: https://petition.parliament.uk/petitions/700062 Diagnosed at a young age, then about 2yrs later your care team notified you of…. What went through your mind when you got that call? What did you do differently in your approach to care? Genetic testing? Upwards of 10% of cancer due to hereditary mutations – CHK2 tumor suppressor gene According to a June 2023 study published in Scientific Advances by lead author Elena Orpeza You can also find this study on BreastCancer.org “Research suggests that a CHEK2 mutation can nearly double the risk of breast cancer. Although not as common as a BRCA1 or BRCA2 mutation, CHEK2 mutations have been found in up to 1.6% of the general population and in 2% to 3% of women diagnosed with breast cancer.” More likely to be Dx with Hormone + / HER-2 negative BC in pre-menopausal women Ave age Dx w/CHEK2 – 46 Ave age w/out CHEK2 – 58 More likely to be resistant to hormonal Tx, than in pre-menopausal women w/out CHEK2 I connected with you on LinkedIn and got to know your story. LinkedIn is a social medial platform mostly used for business networking. More likely to find posts of this sort on Facebook where people may have a closer personal network. Why post on LinkedIn? On a video on WorkingwithCancer.co.uk More people afraid of losing their job, than losing their life. 50% of people will be diagnosed with cancer in our lifetime. https://www.gofundme.com/f/urgent-medical-funds-for-jemma?utm_campaign=p_lico+share-sheet-first-launch&utm_medium=copy_link&utm_source=customer

Eric Williams, a husband, father, and pharmaceutical sales leader, shares his powerful and deeply personal journey with prostate cancer. He details the critical red flags, including an elevated PSA level, and emphasizes the life-saving importance of self-advocacy and pushing for further testing when something doesn't feel right. Eric opens up about his Unsignificant family history of cancer and the pivotal moment he was educated on the need for genetic counseling, a step he then ensured his daughters took. Eric recounts how he and his wife made a conscious choice to fight with courage, transforming his diagnosis from a source of fear into an opportunity to be a light for others in the oncology waiting room. His story of creating "Team E" and connecting with strangers highlights the human connection at the heart of healing and how suffering can be a gift to those around you.Tune in for essential advice on prostate cancer awareness, the necessity of knowing your family history, and pushing for early detection. Eric’s message is a crucial resource for black men's health, stressing that self-advocacy is not optional and that your faith can be your strongest weapon in the fight against cancer.Key Takeaways:Self-advocacy is non-negotiable: Be proactive, ask questions, and push for answers if something feels wrong.Know your family history: Understanding genetic predispositions is crucial for early detection and screening.Early detection saves lives: Do not avoid PSA tests or screenings; know your numbers.Faith can be a foundational weapon: A positive mindset and spiritual belief can provide immense strength during treatment.Your journey can help others: Sharing your experience creates community, breaks down stigmas, and offers hope.Genetic counseling is key: A family history of cancer may warrant genetic testing for you and your family members.#ProstateCancer #MensHealth #BlackMensHealth #CancerSurvivor #Faith #Testimony #SelfAdvocacy #PSA #EarlyDetection #FamilyHistory #GeneticCounseling #CancerAwareness #Oncology #HealthEquity

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcare Genetics For Healthcare: Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0 Facebook: https://www.facebook.com/GeneticsForHealthcare Instagram: https://www.instagram.com/geneticsforhealthcare/ TikTok: https://www.tiktok.com/@genetics.for.healthcare LinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcare Genetics For Healthcare: Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0 Facebook: https://www.facebook.com/GeneticsForHealthcare Instagram: https://www.instagram.com/geneticsforhealthcare/ TikTok: https://www.tiktok.com/@genetics.for.healthcare LinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcare Genetics For Healthcare: Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0 Facebook: https://www.facebook.com/GeneticsForHealthcare Instagram: https://www.instagram.com/geneticsforhealthcare/ TikTok: https://www.tiktok.com/@genetics.for.healthcare LinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareGenetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/#precisionmedicine #healthcare #cancer

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareGenetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/#precisionmedicine #healthcare #cancer

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareGenetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/#precisionmedicine #healthcare #cancer

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareGenetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/#precisionmedicine #healthcare #cancer

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareFor decades, genetic testing was rationed, reserved only for patients who fit narrow, outdated clinical guidelines. But what happens when those guidelines leave countless people at risk? In this episode, clinical geneticist and medical innovator Dr. Ed Esplin of LabCorp Genetics reveals how his team’s groundbreaking research exposed the flaws in restrictive testing policies. Through rigorous studies in breast cancer, colorectal cancer, and beyond, they proved that universal germline genetic testing identifies far more at-risk patients than guidelines ever predicted and fundamentally changes how we treat and prevent disease.The battle wasn’t just scientific. It was systemic. Dr. Esplin shares how irrefutable data challenged institutional gatekeeping, from insurer denials to skeptical clinicians. The data has forced a reckoning: when up to “50% of high-risk patients were being missed”, “standard of care" was anything but standard care. Hear how landmark trials like INTERCEPT and collaborations with the Mayo Clinic turned the tide, proving that equitable access wasn’t just ethical—it was medically necessary.Today, Dr. Esplin’s mission continues: to dismantle barriers wherever they persist. From community oncology clinics to rare disease diagnostics, he makes the case that access to genetic insights should be driven by evidence, not just eligibility criteria. For patients, advocates, and providers alike, this episode is a playbook for turning data into action and a reminder that when guidelines lag behind science, it’s time to rewrite them.Genetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/#precisionmedicine #healthcare #cancer

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareWhat if your DNA could help you avoid serious illnesses before they even start? In this episode of Genetics for Healthcare, we sit down with Dr. Robert Green, a leading medical geneticist at Harvard Medical School, to explore how cutting-edge genomics is transforming healthcare from reactive to proactive.Dr. Green’s work focuses on using whole genome sequencing to uncover hidden health risks—giving people the power to take action early and prevent disease. Dr. Green explains how genetic testing isn’t just for diagnosing rare conditions anymore. Today, it can reveal critical health insights for anyone, from newborns to healthy adults. For example, about 1 in 7 people carry genetic variants that could put them at risk for conditions like heart disease, cancer, or Alzheimer’s—but if caught early, many of these risks can be managed or even prevented. He shares real-world stories from his BabySeq Project, where sequencing newborns uncovered life-changing health clues that traditional medicine missed.Yet despite its potential, integrating genomics into everyday healthcare isn’t simple. Dr. Green discusses challenges like outdated medical systems, insurance hurdles, and the need for better education, while also highlighting exciting solutions, including AI and patient advocacy. He leaves listeners with practical steps to take control of their genetic health, whether through clinical testing, asking the right questions, or joining emerging research programs.Tune in to learn how genomics is shifting medicine from "waiting to get sick" to staying healthy and how you can be part of this revolutionLINKS:Genomes2People: https://www.genomes2people.org/BabySeq Project: https://www.babyseqproject.org/Critical Bottlenecks inRare Disease Research and Care: https://www.genomes2people.org/wp-content/uploads/2025/03/20250228_Zenodo_McMurry_bottlenecks-in-rare-disease-research.pdfGenetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/#oncology #cancer #precisionmedicine

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareAshley Dedmon understands the life-or-death power of speaking up for your health. A BRCA2 previvor, former teen caregiver to both parents with cancer, and passionate health equity advocate, she transforms personal trauma into a powerful lesson on self-advocacy. In this candid and eye-opening conversation, Ashley reveals how systemic gaps in her mother’s cancer care—where providers failed to take family history or offer genetic testing—ignited her mission to empower patients. She describes advocacy as her "God job," a spiritual calling to dismantle healthcare disparities, and shares the three non-negotiable standards she demands from every doctor. Ashley also pulls back the curtain on her battles with insurance companies, including the exhausting process of securing four denial letters just to complete her post-mastectomy reconstruction—proof that persistence is often as crucial as any medical treatment.Determined to break generational silences around health, Ashley authored The Big Discovery, a children’s book helping Black families discuss cancer when few resources reflected their experiences. She even includes her genetic test results in her will, ensuring her daughters inherit more than memories—they inherit knowledge that could save their lives.This episode is essential for anyone who’s ever felt unheard by doctors, faces genetic testing decisions, or wants to turn their voice into an instrument of change. As Ashley puts it: "Your voice costs nothing, but its value? That’s immeasurable. I’ve used mine to argue with insurers, educate physicians, and protect my daughters. Silence isn’t an option when lives hang in the balance."Links:IG: https://www.instagram.com/pinklegacy5050?igsh=cnZ2c2JzNDF0Zzhr&utm_source=qrLBBC profile: https://www.lbbc.org/about-us/team/ashley-deBarns & Noble book link: https://www.barnesandnoble.com/w/the-big-discovery-ashley-dedmon/1146780861?ean=9798989463503Genetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareIn this deeply personal episode oncologist and author Dr. Chadi Nabhan joins host Rome Madison for a conversation that bridges cutting-edge science with timeless human connection. Dr. Nabhan shares the pivotal moment that defined his career—a dying patient's simple request: "Just promise you'll come back tomorrow and smile." This encounter revealed medicine's profound truth: while genetics and AI are revolutionizing cancer treatment (like his work accelerating clinical trials through AI at Right), healing begins with empathy. Dr. Nabhan breaks down complex topics—from genomic tumor testing (reading a cancer's blueprint) to overcoming healthcare distrust with patient stories from his book The Cancer Journey. He offers practical wisdom, urging listeners to ask doctors three key questions about their cancer's origins and targeted treatments, while emphasizing: "No question is stupid." For anyone navigating cancer (patients, caregivers, or providers), this episode is a powerful reminder that precision medicine's future lies not just in DNA, but in the dignity of human connection.Genetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareIn this powerful episode we sit down with Tom Whitehead, co-founder of the Emily Whitehead Foundation along with wife Kari and daughter Emily, to share their incredible story of the first pediatric cancer patient ever treated with CAR-T cell therapy. What began as a desperate fight for survival against acute lymphoblastic leukemia (ALL) became a medical breakthrough that has since helped treat tens of thousands of lives worldwide.Tom recounts the harrowing journey from Emily’s devastating diagnosis at age five to the experimental treatment that defied all odds . . . including a 14-day coma and a last-chance arthritis drug that miraculously turned the tide. He opens up about the emotional toll on their family, the pivotal role of faith in Emily’s recovery, and how their experience inspired them to advocate for greater access to cutting-edge therapies.Today, Emily is a thriving college student, and the Whiteheads’ foundation helps families navigate clinical trials, insurance hurdles, and the hope that CAR-T therapy can bring. Tom also shares practical advice for patients and caregivers facing similar battles, emphasizing the importance of second opinions, persistence, and staying positive in the face of uncertainty.Tune in for an unforgettable conversation about resilience, medical innovation, and how one family’s fight changed the future of cancer treatment.Links & Resources:*- [Emily Whitehead Foundation](https://emilywhiteheadfoundation.org)- Watch the documentary "Medicine and Miracles" (Amazon/Apple)- IMAX film "Superhuman Body: World of Medical Marvels" (featuring Emily’s story)Genetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareIn this episode Rome welcomes Andy Moye PhD, healthcare industry executive and AI expert, to discuss the transformative role of artificial intelligence in genetics and precision medicine. AI isn’t just a buzzword . . . it’s a tool to make healthcare more accurate, accessible, and human-centered.Andy explains that AI, at its core, is advanced pattern recognition, helping doctors analyze complex data at the point-of-care like: genetic sequences, medical images, and clinical records to improve diagnoses and treatment plans. He highlights how AI can reduce human error in fields like radiology and pathology, where fatigue and subjectivity can lead to missed or incorrect diagnoses.The conversation shifts to the challenges of integrating AI into healthcare, including the need for high-quality training data and clinician trust. Andy emphasizes that AI isn’t about replacing doctors and other healthcare employees, but supporting them, especially in overburdened systems where human resources are stretched thin.Rome and Andy also explore the ethical balance between innovation and regulation, noting that while AI doesn’t need to be perfect, it must be reliable enough to enhance decision-making without stifling progress.The episode ends on a personal note, with Andy recounting his experience during 9/11 while deployed overseas, tying his leadership journey to his mission in healthcare.Genetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareAfter her mother’s battle with breast cancer, Caroline became vigilant about early detection. But when her own diagnosis came, the real surprise wasn’t just the cancer, it was the genetic revelation that followed. A PMS2 mutation unlocked a hidden risk for multiple cancers, forcing Caroline to make life-altering decisions not just for herself, but for her entire family.Now a fierce advocate, Caroline reveals how she turned fear into action, pushing for genetic testing to become standard care—and why so many doctors still overlook it. Her story is a wake-up call: knowledge isn’t just power—it’s survival.Genetics For Healthcare:Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcare(Episode trigger warning: Descriptions of severe medical trauma.)In this powerful episode, Karen shares:- Why thousands of cancer patients are being poisoned because DPYD testing isn’t standard in the U.S.—unlike Europe.- How underreporting of adverse events masks the true death toll from excessive toxicity. Many fatalities are not accurately noted because patients aren’t being tested.- The shocking financial cost of ignoring this test—half a million dollars wasted on one preventable death.- A recent victory: The FDA updated safety labels for fluoropyrimidines, but most doctors still don’t know DPYD testing exists.- How patients are fighting back! Including one woman who demanded the test, discovered she was DPD-deficient, and saved her own life.If you or a loved one are facing chemotherapy, this episode could be the difference between life and death. Learn the critical questions to ask your oncologist—before starting treatment.🔗Resources & Advocacy: DPYD Foundation: https://www.dpyd.org #TestBeforeChemoColorectalCancer Alliance: https://colorectalcancer.org/sites/default/files/media/documents/5FU_guide.pdfKaran Merritt, co-founder Advocates for Universal DPD/DPYD Testing www.test4dpd.orgGenetics For Healthcare:Spotify: ⁠⁠https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0⁠⁠Facebook: ⁠⁠https://www.facebook.com/GeneticsForHealthcare⁠⁠Instagram: ⁠⁠https://www.instagram.com/geneticsforhealthcare/⁠⁠TikTok: ⁠⁠https://www.tiktok.com/@genetics.for.healthcare⁠⁠LinkedIn: ⁠⁠https://www.linkedin.com/company/genetics-for-healthcare-podcast/⁠#PrecisionMedicine #CancerCare #PatientAdvocacy

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareIn this podcast episode, Rome Madison and Kristine discuss pharmacogenomics (PGx), the study of how genetics influence individual responses to medications. Kristine explains that genetic variations influence liver enzymes in drug metabolism, causing differences in drug processing. PGx testing can prevent toxic buildup of prescription drugs, improve treatment outcomes, and save lives. For example, some people may process medications too slowly causing a buildup of the drug in the body that can lead to fatal toxicity. Some people metabolize drugs or too quickly, eliminating the drug from the body too fast, leading to reduced effectiveness. PGx testing, through a simple genetic panel, can identify these variations, helping healthcare providers tailor medications to individual patients. This approach can reduce adverse drug events, improve treatment outcomes, and lower healthcare costs. Kristine emphasizes the importance of patient advocacy and highlights studies showing significant reductions in hospitalizations and emergency visits with PGx guided care. The conversation underscores the potential of PGX to revolutionize precision medicine, improve patient safety and reduce healthcare costs. Genetics for Healthcare: Spotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0 Facebook: https://www.facebook.com/GeneticsForHealthcare Instagram: https://www.instagram.com/geneticsforhealthcare/ TikTok: https://www.tiktok.com/@genetics.for.healthcare LinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/ CPIC Guidelines: https://cpicpgx.org/guidelines/ #Pharmacogenetics #PersonalizedMedicine #HealthcareInnovation

This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareIn this episode Rome interviews Dr. Alan Wu, Chief of Clinical Chemistry and Toxicology at Zuckerberg San Francisco General Hospital and Professor of Laboratory Medicine at UCSF. He emphasizes the critical role of laboratories in healthcare, noting that 70% of medical decisions are based on clinical laboratory tests, yet the lab often remains behind the scenes and underappreciated.Dr. Wu discusses his innovative use of social media, particularly TikTok, to educate the public about laboratory medicine. His channel #LabTales has garnered significant traction, with over 50,000 followers and over six million views. He explains how social media allows for rapid dissemination of information, and highlights his research on using social media to promote lab medicine, published in the Journal of Applied Laboratory Medicine.The conversation touches on the importance of patient access to laboratory tests, particularly in precision medicine, and how legislation like the LDT (Laboratory Developed Tests) regulation could hinder innovation. Dr. Wu stresses the need for patients to be more involved in their healthcare decisions, advocating for greater awareness and understanding of laboratory tests and genetics.Dr. Alan WuWebsite: alanhbwu.comLabTales TikTok: https://www.tiktok.com/@labtalesArticle: https://academic.oup.com/jalm/article-abstract/10/1/192/7931431?redirectedFrom=fulltextOncology Central: https://www.oncology-central.com/Genetics for HealthcareSpotify: https://open.spotify.com/show/5tvMOrd9RyHLdOEGFNWavq?si=18815af6d1fe4da0Facebook: https://www.facebook.com/GeneticsForHealthcareInstagram: https://www.instagram.com/geneticsforhealthcare/TikTok: https://www.tiktok.com/@genetics.for.healthcareLinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/